<?xml version="1.0" encoding="UTF-8"?>
<p id="par0090">Shen et al. has applied 400 mL CP therapy including SARS-CoV-2 antibodies (titer&gt; 1:40) to 5 critical patients (age range 30–70, two women) determined by Elisa test. After CP transfusion between the 10th and 22nd days of admission to the hospital, symptoms such as an increase in viral antibody titers, a decrease in SARS-Cov-2 viral loads and normalization of ARDS and fever decreased were observed [
 <xref rid="bib0075" ref-type="bibr">15</xref>].
</p>
